.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,109,205

« Back to Dashboard

Claims for Patent: 7,109,205

Title:Carboxylic acid derivatives, their preparation and use
Abstract:Carboxylic acid derivatives ##STR00001## where R R.sup.6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
Inventor(s): Riechers; Hartmut (Neustadt, DE), Klinge; Dagmar (Heidelberg, DE), Amberg; Wilhelm (Friedrichsdorf, DE), Kling; Andreas (Mannheim, DE), Muller; Stefan (Speyer, DE), Baumann; Ernst (Dudenhofen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: Abbott GmbH & Co. KG (Wiesbaden, DE)
Application Number:10/602,275
Patent Claims: 1. A compound having the formula: ##STR00016## wherein: X is CH; Y is oxygen; Z is oxygen; R is CO.sub.2H; R.sup.2 is methyl; R.sup.3 is methyl; R.sup.4 is phenyl; R.sup.5 is phenyl; and R.sup.6 is methyl, or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1, wherein said compound is an optically active enantiomer.

3. The compound of claim 2, wherein the enantiomer is the S enantiomer.

4. The compound of claim 3, wherein the enantiomer is the pure form of the S enantiomer.

5. The compound of claim 2, wherein the enantiomer is the R enantiomer.

6. The compound of claim 5, wherein the enantiomer is the pure form of the R enantiomer.

7. A pharmaceutical composition comprising a compound having the formula: ##STR00017## wherein: X is CH; Y is oxygen; Z is oxygen; R is CO.sub.2H; R.sup.2 is methyl; R.sup.3 is methyl; R.sup.4 is phenyl; R.sup.5 is phenyl; R.sup.6 is methyl; or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

8. The composition of claim 7, wherein said composition is suitable for oral, parenteral, or nasopharyngeal delivery.

9. The composition of claim 7, wherein the composition is in a solid form.

10. The composition of claim 7, wherein the composition is in a liquid form.

11. The composition of claim 7, wherein the composition is in the form of a tablet, capsule, powder, granule, suppository, solution, colloid, ointment, cream, vapor or spray.

12. The composition of claim 7, wherein the carrier comprises a tablet binder, filler, preservative, tablet disintegrant, flow regulator, plasticizer, wetting agent, dispersant, emulsifier, solvent, release-slowing agent, antioxidant, or propellant gas.

13. The composition of claim 7, wherein the compound is an optically active enantiomer.

14. The composition of claim 13, wherein the enantiomer is the S enantiomer.

15. The composition of claim 14, wherein the enantiomer is the pure form of the S enantiomer.

16. The composition of claim 13, wherein the enantiomer is the R enantiomer.

17. The composition of claim 16, wherein the enantiomer is the pure form of the R enantiomer.

18. The compound ##STR00018##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc